A patient with proven Legionnaire's disease is described whose clinical condition improved with intravenous azithromycin after failure to respond to treatment with erythromycin and rifampicin. (Thorax 1994;49:620-621) Infection with Legionella pneumophila is a relatively uncommon cause of pneumonia in adults, accounting for 2-6% of cases acquired in the community in the United Kingdom. 
Infection with Legionella pneumophila is a relatively uncommon cause of pneumonia in adults, accounting for 2-6% of cases acquired in the community in the United Kingdom.i Erythromycin has been the agent of choice in the treatment of Legionella pneumonia, but therapeutic failures have been documented2 and antibiotic resistance due to emergence of mutant strains has been demonstrated in vitro. 3 Recently, macrolides such as azithromycin have been shown to have superior activity against L pneumophila in an animal model of Legionnaire's disease. 4 We report a case of Legionnaire's disease where intravenous azithromycin was antimicrobial treatment was therefore changed to intravenous erythromycin, 1 g six hourly, and cefotaxime, 1 g eight hourly. Legionella serogroup 1 antigen was detected in his urine by enzyme linked immunosorbent assay three days later.
Over the following three days he deteriorated so intravenous rifampicin 300 mg daily was added. Total parenteral nutrition was commenced in view of his catabolic state. An elective tracheostomy was performed.
Ten days after admission his renal function deteriorated, his serum creatinine rising to 129 imol/l and urea to 12 5 mmol/l. Urine biochemical analysis was compatible with established renal failure: urine sodium was 309 mmol/24 hours (normal range 100-250 mmol/24 hours) and urine potassium was within the normal range at 94 mmol/24 hours. In addition, proteinuria of 2 g in 24 hours was observed. There was no evidence of a disseminated intravascular coagulopathy.
Pulmonary artery flotation catheter studies showed that the pulmonary artery pressure was 64/34 mm Hg (normal range 15-30/ 3-15 mm Hg) and pulmonary capillary wedge pressure was 17 mm Hg (normal range 6-12 mm Hg); cardiac output was 18 1/min (normal 5-5 5 1/min) and systemic vascular resistance was 408 dynes s cm-5 (normal range 900-1200). The elevated pulmonary capillary pressure was attributed to fluid overload and the raised cardiac output, together with a low systemic vascular resistance, were compatible with his sepsis syndrome. Continuous arteriovenous haemofiltration was therefore commenced.
The patient's clinical condition deteriorated further and treatment with intravenous azithromycin was initiated (fig 2) . The patient received a dose of 250 mg 12-hourly on the first day followed by a dose of 250 mg once daily for 13 days. After 48 hours of treatment both clinical and radiological improvement were observed ( Intravenous azithromycin in Legionnaire's disease titre of 1/512 to serogroup 1 compared with a baseline value of < 1/16. Titres to serogroup 6 rose to 1/256. The patient's clinical condition continued to improve. He required haemodialysis for a further week and was discharged five weeks later, since when he has remained well with normal renal function and a normal chest radiograph.
Discussion
We describe a patient with proven severe Legionella pneumonia whose clinical condition improved with intravenous azithromycin. Azithromycin differs structurally from the macrolide erythromycin by the insertion of a methyl substituted nitrogen at position 9a in the lactone ring creating a 15 numbered structure. This modification leads to an extension of the broad spectrum of activity against Gram positive and Gram negative bacteria. 
